* Pulmonx Corp LUNG.OQ reported a quarterly adjusted loss
of 43
cents per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 37 cents per share.
* Revenue rose 16.7% to $10.79 million from a year ago;
analysts
expected $9.26 million.
* Pulmonx Corp's reported EPS for the quarter was a loss
of 43
cents.
* The mean earnings estimate of analysts had fallen by
about 16.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Pulmonx Corp shares had risen by 1.1% this quarter and
lost 21.8% so far this year.
* The company reported a quarterly loss of $15.83 million.
* Wall Street's median 12-month price target for Pulmonx
Corp is
$32.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated May 4 at 12:48 a.m. All
figures in US dollars unless otherwise stated